Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.

about

Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.

Item

http://www.wikidata.org/entity/Q48364827

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Elucidating the impact of low ...... e experimental Chagas disease.

@en

Elucidating the impact of low ...... e experimental Chagas disease.

@nl

type

Item

label

Elucidating the impact of low ...... e experimental Chagas disease.

@en

Elucidating the impact of low ...... e experimental Chagas disease.

@nl

prefLabel

Elucidating the impact of low ...... e experimental Chagas disease.

@en

Elucidating the impact of low ...... e experimental Chagas disease.

@nl

P1476

Elucidating the impact of low ...... te experimental Chagas disease

@en

P2093

Laura E Fichera

http://www.w3.org/2001/XMLSchema#string

Marcela S Rial

http://www.w3.org/2001/XMLSchema#string

María L Scalise

http://www.w3.org/2001/XMLSchema#string

Mónica I Esteva

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations

Historical Perspectives on the Epidemiology of Human Chagas Disease in Texas and Recommendations for Enhanced Understanding of Clinical Chagas Disease in the Southern United States

In vitro and in vivo trypanocidal activity of H2bdtc-loaded solid lipid nanoparticles

In vitro and in vivo investigation of the efficacy of arylimidamide DB1831 and its mesylated salt form--DB1965--against Trypanosoma cruzi infection

Fexinidazole: a potential new drug candidate for Chagas disease

Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.

Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease.

New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients

Developments in the management of Chagas cardiomyopathy.

P304

e0006119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PNTD.0006119

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Claudio J. Salomon

Eva C Arrúa

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29267280

http://www.w3.org/2001/XMLSchema#string

P921

Chagas disease

P932

5755931

http://www.w3.org/2001/XMLSchema#string